Form D · Biotechnology
AcuFocus, Inc.
Irvine, CA · CIK 0001165260
Offering snapshot reported Aug 20, 2018 · SEC filing
- Reported sold
- $24M Offering amount: $26M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 8, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 20, 2018 | Initial | $23,974,000 | No comparison | 15 | SEC filing |
| Oct 5, 2016 | Initial | $74,924,639 | No comparison | 19 | SEC filing |
| Aug 24, 2016 | Initial | $2,000,000 | No comparison | 15 | SEC filing |
| Jul 8, 2016 | Initial | $1,866,084 | No comparison | 14 | SEC filing |
| May 11, 2016 | Amendment | $5,800,000 | $1,749,595vs Mar 30, 2016 | 17 | SEC filing |
| Mar 30, 2016 | Initial | $4,050,405 | No comparison | 16 | SEC filing |
| Nov 24, 2015 | Initial | $1,998,474 | No comparison | 11 | SEC filing |
| Sep 12, 2014 | Initial | $15,240,189 | No comparison | 20 | SEC filing |
| Dec 28, 2011 | Initial | $41,868,522 | No comparison | 23 | SEC filing |
| Dec 24, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-319627
Source: Form D, filed Aug 20, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arjun Arora | Director |
| Buzz Benson | Director |
| James Garvey | Director |
| Robert E. Grant | Director |
| Charles Larsen | Director |
| Richard L. Lindstrom, M.D. | Director |
| William J. Link | Director |
| Greg Madden | Director |
| James V. Mazzo | Director, Executive |
| Edward W. Peterson | Director, Executive |
| Ali Satvat | Director |
| Ryan M. Schwarz | Director |
| Gloria Sefton | Executive |
| Jim Socks, Od | Executive |
| Jason Tester | Executive |
| Steven M. Waite | Director |
| Conrad Wang | Director |
| Charles M. Warden | Director |
| Alan Waterhouse | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
32 Discovery, Suite 200
Irvine, CA, 92618-3161
Irvine, CA, 92618-3161